Chemomab Therapeutics Ltd. (CMMB)
NASDAQ: CMMB · Real-Time Price · USD
3.390
-0.110 (-3.14%)
Oct 9, 2025, 4:00 PM EDT - Market closed

Chemomab Therapeutics Statistics

Total Valuation

CMMB has a market cap or net worth of $17.54 million. The enterprise value is $8.04 million.

Market Cap17.54M
Enterprise Value 8.04M

Important Dates

The next estimated earnings date is Thursday, November 13, 2025, before market open.

Earnings Date Nov 13, 2025
Ex-Dividend Date n/a

Share Statistics

CMMB has 5.17 million shares outstanding. The number of shares has increased by 67.27% in one year.

Current Share Class n/a
Shares Outstanding 5.17M
Shares Change (YoY) +67.27%
Shares Change (QoQ) +1.61%
Owned by Insiders (%) 16.73%
Owned by Institutions (%) 20.43%
Float 4.02M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 1.87
P/TBV Ratio 1.79
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 7.42

Current Ratio 7.42
Quick Ratio 7.32
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -120.16% and return on invested capital (ROIC) is -79.03%.

Return on Equity (ROE) -120.16%
Return on Assets (ROA) -61.70%
Return on Invested Capital (ROIC) -79.03%
Return on Capital Employed (ROCE) -130.65%
Revenue Per Employee n/a
Profits Per Employee -$591,300
Employee Count20
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -36.77% in the last 52 weeks. The beta is 0.52, so CMMB's price volatility has been lower than the market average.

Beta (5Y) 0.52
52-Week Price Change -36.77%
50-Day Moving Average 3.25
200-Day Moving Average 5.18
Relative Strength Index (RSI) 66.82
Average Volume (20 Days) 230,479

Short Selling Information

Short Interest 123,398
Short Previous Month 130,446
Short % of Shares Out 2.39%
Short % of Float n/a
Short Ratio (days to cover) 0.86

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -12.67M
Pretax Income -11.83M
Net Income -11.83M
EBITDA -12.61M
EBIT -12.67M
Earnings Per Share (EPS) -$2.12
Full Income Statement

Balance Sheet

The company has $9.37 million in cash and n/a in debt, giving a net cash position of $9.37 million or $1.81 per share.

Cash & Cash Equivalents 9.37M
Total Debt n/a
Net Cash 9.37M
Net Cash Per Share $1.81
Equity (Book Value) 9.70M
Book Value Per Share 1.87
Working Capital 9.18M
Full Balance Sheet

Cash Flow

Operating Cash Flow -14.34M
Capital Expenditures n/a
Free Cash Flow -14.34M
FCF Per Share -$2.77
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

CMMB does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -67.27%
Shareholder Yield -67.27%
Earnings Yield -67.96%
FCF Yield -82.40%

Analyst Forecast

The average price target for CMMB is $26.50, which is 681.71% higher than the current price. The consensus rating is "Strong Buy".

Price Target $26.50
Price Target Difference 681.71%
Analyst Consensus Strong Buy
Analyst Count 2
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) -44.53%
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on August 26, 2025. It was a reverse split with a ratio of 1:4.

Last Split Date Aug 26, 2025
Split Type Reverse
Split Ratio 1:4

Scores

Altman Z-Score n/a
Piotroski F-Score 1